New Potential Therapies for Chronic Hepatitis B / 대한소화기학회지
Korean J. Gastroenterol. (Online)
; : 267-273, 2019.
Article
de Ko
| WPRIM
| ID: wpr-787215
Bibliothèque responsable:
WPRO
ABSTRACT
A HBV infection is a dynamic disease and long-term liver inflammation contributes to the development of liver cirrhosis and hepatocellular carcinoma. Currently available nucleos(t)ide analogues and pegylated interferon are effective in inhibiting HBV replication but rarely achieve HBsAg clearance. The present article introduces a new definition of HBV cure and several emerging therapies for HBV cure, including direct acting antivirals and immune modulatory antivirals.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Antiviraux
/
Virus de l'hépatite B
/
Interférons
/
Carcinome hépatocellulaire
/
Hépatite B chronique
/
Antigènes de surface du virus de l'hépatite B
/
Hépatite chronique
/
Inflammation
/
Foie
/
Cirrhose du foie
langue:
Ko
Texte intégral:
Korean J. Gastroenterol. (Online)
Année:
2019
Type:
Article